Lipids and lipoproteins in a group of patients with ischemic cerebrovascular disease;Lipidos y lipoproteinas en un grupo de pacientes con enfermedad cerebrovascular isquemica

Revista de Neurologia

Volumn 27, Issue 159, 1998, Pages 804-808

  Scherle, C E ^a,b   Nasiff, A ^a   Begueria R A ^a   Perez Nellar J ^a   Colina Rodriguez A J ^a  

^a HOSPITAL CLINICOQUIRÚRGICO HERMANOS AMEIJEIRAS   (Cuba)

^b NONE   (Cuba)

Author keywords

Cerebrovascular disease; Lipids; Lipoproteins

Indexed keywords

APOLIPOPROTEIN B; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; LIPID; LIPOPROTEIN; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADULT; AGED; ARTICLE; BRAIN INFARCTION; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; LIPID BLOOD LEVEL; MALE; BLOOD; BRAIN ISCHEMIA; COMORBIDITY; CUBA; DIABETES MELLITUS; HYPERTENSION; MIDDLE AGED; RACE; RETROSPECTIVE STUDY; RISK FACTOR; SMOKING;

AGED; AGED, 80 AND OVER; APOLIPOPROTEINS B; BRAIN ISCHEMIA; CEREBRAL INFARCTION; COMORBIDITY; CONTINENTAL POPULATION GROUPS; CUBA; DIABETES MELLITUS; FEMALE; HUMANS; HYPERTENSION; LIPIDS; LIPOPROTEINS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; SMOKING;

EID: 0031740882     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.27159.98086     Document Type: Article

References (52)

1. Cortellaro M, Baldassare D, Cofrancesco E, et al. Relation between hemostatic variables and increase of common carotid intima-media thickness in patients with peripheral arterial diseases. Stroke 1996; 27: 450-4.
2. Rössner S. Serum lipoproteins and ischemic vascular disease. On the interpretations of serum lipids versus lipoprotein concentrations. J Cardiovasc Pharmacol 1982; 4: 201.
3. World Health Organization Task Force on the Stroke and Other Cerebrovascular Disorders. Recommendations on stroke prevention, diagnosis and therapy. Stroke 1989; 20: 1407-31.
4. Wang KJ, Schoenberg BS, et al. Serum cholesterol, its lipoprotein fractions among survivors of cerebrovascular disease. A case control study. Neuroepidemiology 1989; 8: 175-83.
5. Woo J, Lam CWK, et al. Acute and long term changes in serum lipids after acute stroke. Stroke 1990; 21: 1407-11.
6. Lindgren A, Nilsson-Ehle P, Norrving B, Johansson BB. Plasma lipids and lipoproteins in subtypes of stroke. Acta Neurol Scand 1992; 86: 572-8.
7. Anuario Estadístico de Cuba. MINSAP 1995; 35-53.
8. Morejón SC, Seisdedos MA, Vivo LLA. Estudio de lipidos en pacientes con trombosis cerebral. Rev Cubana Med 1988; 27: 78-86.
9. Ruiz LJ, Ferer IJ, Acosta SL, Miranda DN, Gómez SL. Apolipoproteína-B sérica en diferentes manifestaciones clínicas de aterosclerosis. Rev Cubana Med 1987; 26: 753-8.
10. Echevarría AR, Miret PH, Rodríguez LE, Rodríguez GE, Pombo HL. Lipoproteínas y lipidos séricos en pacientes menores de 40 años con cardiopatía coronaria. Rev Cubana Med 1985; 24: 1063-9.
11. Miembros de la Clínica Mayo. Examen clinico neurológico. Prensa Médica Mexicana 1970.
12. The fifth report of the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure. National High Blood Pressure Education Program. National Institute of Health, National Heart, Lung and Blood Institute. NIH; 1993. p. 93-1088.
13. Van Kooten F, Hoogerbrugge N, Naarding P, Koudstaal PJ. Hyperglycemia in the acute phase of stroke is not caused by stress. Stroke 1993; 24: 1129-32.
14. Sabin AJ. Etiopatogenia de la isquemia cerebral. En Castillo J, Martínez-Vila E, eds. Trombosis, fármacos antitrombóticos y enfermedad cerebrovascular. Barcelona: Prous; 1995. p. 381-408.
15. Sorrell L, López J, Cabrera M. Cuantificación de apo B con anticuerpos monoclonales como indicador de riesgo aterogénico. Interferón y Biotecnología 1989; 6: 258-64.
16. Sorrell L, Pérez M, Rodríguez M. A sandwich ELISA based on anti-apo B monoclonal antibodies for lipoprotein (a) measurement. Clin Chim Acta 1995; 236: 59-70.
17. Siedel J, et al. Methods der enzimatis chem analise. Clin Chem 1983; 29: 1075.
18. Boehringer Manheim. Diagnostic triglycerides. CPO PAP 1989; 189.
19. López-Virella MF, et al. Comparison of 3 methods of selective isolation for HDL determination. Clin Chem 1977; 23: 882.
20. Lipo-Merz. Metabolismo lipídico y aterosclerosis. 1986; 11.
21. Robbins SL. Patología estructural y funcional. México: Interamericana; 1975. p. 569-84.
22. Kannel WB, Dawler TR, Cohem M, et al. Vascular disease of the brain. Epidemiologic aspects. The Frammingham study. Am J Public Health 1965; 55: 1355-61.
23. Fogelholm R, Aho K. Ischemic cerebro vascular disease in young adults. Acta Neurol Scand 1973; 49: 428-33.
24. Kagan A, Popper JS, Rhoads GG, et al. Factors related to stroke incidence in Hawai Japanese men: the Honolulu Heart Study. Stroke 1980; 11: 14-21.
25. Tamaka H, Ueda Y, Hayashi M, et al. Risk factor of cerebral hemorrhage and cerebral infarction in a Japanese rural community. Stroke 1982; 13: 62-73.
26. Shintani S, Kikuchi S, Hamagushi H, Shiigai T. High serum lipoprotein (a) levels are an independent risk factor for cerebral infarction. Stroke 1993; 24: 965-9.
27. Duncan GW, Lees RS, Ojemann AG, et al. Concomitants of atherosclerotic carotid artery stenosis. Stroke 1977; 8: 665-9.
28. Rössner S, Kjellin KG, Mettinger KL, Siden A, Soderstrom CE. Normal serum cholesterol but low high density lipoprotein cholesterol concentration in young patients and cerebrovascular disease. Lancet 1978; 1: 577-9.
29. Nubiola AR, Masana L, Masden S, et al. High density lipoprotein cholesterol in cerebrovascular disease. Arch Neurol 1981; 38: 468-71.
30. Van Merode T, Hich P, Hoeks APG, Reneman RS. Serum HDL/total cholesterol ratio and blood pressure in asymptomatic atherosclerotic lesions of the cervical carotid arteries in men. Stroke 1985; 16: 34-8.
31. Woo J, Lam CWK, Kay R, Wong HY, Teoh R, Nicholls MG. Acute and long-term changes in serum lipids after acute stroke. Stroke 1990; 21: 1407-11.
32. Murai A, Tanaka T, Miyahara T, Kaweyema M. Lipoprotein abnormalities in the pathogenesis of cerebral infarction and transient ischemic attack. Stroke 1981; 12: 167-72.
33. Adams RJ, Carroll RM, Nichols FT, et al. Plasma lipoproteins in cortical versus lacunar infarction. Stroke 1989; 20: 448-52.
34. Boutron CM, Giroud M, Gras P, et al. Plasma lipoproteins in cortical infarction versus transient ischemic attacks: a case control study. J Neurol 1993; 240: 133-8.
35. Méndez I, Hachinski V, Wolfe B. Serum lipids after stroke. Neurology 1987; 37: 507-11.
36. Mainard F, Krampf M, Mussini JM, Janssen-Diet F, Madec Y. Bilan lipidique au cours de l'infarctus cérébral dans la phase précoce et au 4e mois. Conséquences pratiques. Presse Med 1988; 23: 1204-5.
37. Staessen J, Amery A, Birkenhger W, et al. Is a high serum cholesterol level associated with longer survival in elderly hypertensive? Hypertens 1990; 8: 755-61.
38. Feldman RG, et al. Serum lipoprotein abnormalities in patients with ischemic cerebrovascular disease. Arch Neurol 1964; 10: 91-100.
39. Aronow WS, Anh C, Gutstein H. Risk factor for new atherothrombotic brain infarction in 664 older women. Am J Cardiol 1996; 77: 1381-3.
40. Guyton CA. Tratado de fisiologia médica. 7 ed. Tomo II. La Habana. Edición Revolucionaria; 1984. p. 814-7.
41. 1-lipoprotein in patients with coronary heart disease. Clin Genet 1974; 6: 230-5.
42. Seed M, Hoppichler F, Reavcley D, Mc Carthy S, Thompson Gr, Boerwinkle E, et al. Relation of serum lipoprotein (a) concentration and apoliprotein (a) phenotype to coronary heart disease in patients with familial hypercholesterolemia. N Engl J Med 1990; 322: 1494-9.
43. Lawn RM. Lipoprotein (a) and atherosclerosis. Ann Intern Med 1991; 115: 209-18.
44. Miles LA, Fless GM, Levin EG, Scanu AM, Plow EF. A potential basis for the thrombotic risk associated with lipoprotein (a). Nature 1989; 339: 301-3.
45. Scanu AM, Scandiani L. Lipoprotein (a): structure, biology and clinical relevance. In Stollerman GH, ed. Mosby Year Book. St Louis: Mosby; 1991. p. 249-70.
46. Wolf K, Ruth M, Niendorf A, Beisiegel U, Dietel M. Morphological co-localization of apoprotein (a) and fibrin (ogen) in human coronary atheromas. Circulation 1989; 80 (Suppl): 20-78.
47. Hajjar KA, Gavish D, Breslow JL, Nachman RL. Lipoprotein (a) modulation of endotelial cell surface fibrinolysis and its potential role in atherosclerosis. Nature 1989; 339: 303-5.
48. Schreiner PJ, Chambless LE, Brown SA, et al. Lipoprotein (a) as a correlate of stroke and transient ischemic attack prevalence in a biracial cohort: The AIRC study. Ann Epidemiol 1994; 4: 351-9.
49. Denti L, Manchini L, et al. Lipoprotein Lp (a) and cerebrovascular disease in the elderly: correlations with the severity of extracranial carotid atherosclerosis assessed by ultrasonography. Acta Biomed Ateneo Parmense 1995; 66: 175-83.
50. Van Kooten F, van Krimppen J, Dippel JWD, et al. Lipoprotein (a) in patients with acute cerebral ischemia. Stroke 1996; 27: 1231-5.
51. Woo J, Lau E, Lam CWK, Kay R, Teoh R, et al. Hypertension, lipoprotein (a) and apolipoprotein A-I are independent risk factors for stroke in a Chinese population. Stroke 1991; 22: 203-8.
52. Bachorik PS, Leny RI, Rifkind BM. Lipids and dyslipoproteinemia. In Henry JB, ed. Clinical diagnosis and management by laboratory methods. 18 ed. WB Saunders; 1991. p. 188-214.